Searched for
MHRA REGISTRATION
Lord’s Mark strengthens UK and UK allied market strategy with regulatory backing for IVD portfolio.In an exciting development, Lord's Mark Industries has secured registration for its In-Vitro Diagnostic portfolio with the MHRA, significan...
Lord’s Mark secures MHRA registration for dialysis device, plans UK expansionLord's Mark Industries Limited has successfully secured regulatory registration from the MHRA for its innovative haemodialysis machine, pav...
Oman to fast-track nods to Indian pharma products registered by US, UK, EuropeOman has also requested India to consider negotiating a preferential trade agreement, the commerce and industry ministry said.
Torrent & Aurobindo receive licenses to sell Pfizer's COVID pill Paxlovid in India, low income countriesThe oral COVID-19 treatment comprises of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating and ritonavir...
Regular market approval granted for Covishield, Covaxin for use in adult populationUnder the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adver...
Foreign produced COVID-19 vaccines: Decision on emergency use applications to be taken in 3 daysThe Central Drug Authority, CDSCO, will process applications for registration certificates (registration of overseas manufacturing site and...
How the world has sped up vaccine approvalsAs authorities in the US and Europe probe other candidates, here is how countries have sped up their approval procedures to face up to the ...
China should open up to Indian generic drugs: ExpertsThe existing cumbersome drug registration procedure in China has dampened enthusiasm among Indian cos seeking entry into China.
Ranbaxy drugs fine, say WHO, UK regulatorUK has issued a statement clarifying that they have found no evidence that any of Ranbaxy’s products in the UK market “are or have been of ...
Bafna Pharmaceuticals recommends 6% dividend for 2012-13The Board of Directors of Bafna Pharmaceuticals at its meeting held on May 20, 2013 have recommended 6% dividend.
- Claris receives MHRA approval for Ahmedabad unit
Claris Lifesciences Limited today announced that it has received approval for its plant at Ahmedabad from the MHRA of the United Kingdom.